Emergent BioSolutions Inc.
EBS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$191 | -$761 | -$212 | $231 |
| Dep. & Amort. | $109 | $125 | $143 | $124 |
| Deferred Tax | -$6 | -$9 | -$29 | $47 |
| Stock-Based Comp. | $18 | $23 | $45 | $42 |
| Change in WC | $89 | -$70 | -$2 | -$156 |
| Other Non-Cash | $39 | $485 | $20 | $34 |
| Operating Cash Flow | $59 | -$206 | -$34 | $321 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$23 | -$52 | -$116 | -$225 |
| Net Acquisitions | $0 | $270 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $148 | -$6 | -$266 | $0 |
| Investing Cash Flow | $125 | $212 | -$381 | -$225 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$198 | -$543 | $564 | -$36 |
| Stock Issued | $9 | $8 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$82 | -$106 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$1 | -$1 | $1 |
| Financing Cash Flow | -$190 | -$536 | $481 | -$141 |
| Forex Effect | $0 | -$1 | $1 | -$0 |
| Net Chg. in Cash | -$6 | -$531 | $66 | -$45 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $112 | $643 | $576 | $622 |
| End Cash | $106 | $112 | $643 | $576 |
| Free Cash Flow | $36 | -$258 | -$150 | $96 |